Navigation Links
Patients In Hospital ICUs At Risk From Medical Errors

Research points out that patients in the ICU of the hospitals may face an increased risk of medical errors and adverse events. The study is published in the August issue // of Critical Care Medicine.

Researchers found that over 20 percent of the patients admitted to two intensive care units at an academic hospital, a medical intensive care unit (MICU) and a coronary critical care unit (CCU), experienced an adverse event. Because these patients are among the sickest, they may be more vulnerable to errors in care, and therefore more susceptible to injury. Of the adverse events in the sample, almost half (45 percent) of them were preventable. A significant number of the adverse events involved medications—most commonly, giving patients the wrong dose. Over 90 percent of all incidents occurred during routine care, not on admission or during an emergency intervention.

“Even though this is a small study, it demonstrates the potential for harm in our critical care units in a dramatic way,” said AHRQ Director Carolyn M. Clancy, M.D. “These findings are another call to action in our efforts to reduce medical errors and improve patient safety.”

The researchers conducted direct continuous observations in the MICU and CCU during nine 3-week periods, distributed throughout 12 months from July 2002 through June 2003. This was supplemented by confidential incident reporting, a computerized adverse drug event detection monitor and chart reviews.

According to the researcher, critical care units provide an increasingly greater proportion of care. “During our lifetimes, we can expect to be admitted to an ICU at least once. We hope these findings will stimulate the adoption of known interventions, like ensuring hand washing, better physician/nurse communications, and greater use of health IT,” the author had said.

-(Source: Newswise
'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
(Date:12/2/2008)... The Health Story Project was anno...formerly known as “Clinical Document Archite...CDA4CDT will continue as the label for the technic...d to Health Level Seven (HL7) for ballot. The new ...Wire EON) December 2, 2008 -- "Our group has...
(Date:12/2/2008)...OR, Mich.---Older people tend to feel about 13 yea...is one of the findings of a study forthcoming in t... . The researchers analyzed the responses of 516 m...the Berlin Aging Study, tracking how their percept...hanged over a six-year period. , "People general...
(Date:12/2/2008)...elease is available in French . , Deep venous... the lower limbs, is the third-most common vascula...stroke, and is a frequent complication in hospital...ion that can lead to rapid death from pulmonary em... health concern that the U.S. Surgeon General and ...
(Date:12/2/2008)... WASHINGTON, Dec. 2 ...l deliver the Keynote address at eHealth Initiativ... the Pulse of Health IT: A Critical Review of Prog...ons for 2009 and Beyond." , , (Logo: http:..., , The Keynote speech will begin at 4:30 p...
Breaking Medicine News(10 mins):Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 2Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 3Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 4Health News: "The Health Story Project" Adopted as New Brand by CDA4CDT : New Brand Underscores Comprehensive Electronic Health Records 5Health News:Old as you want to be: Study finds most seniors feel younger 2Health News:Thrombosis patients face greater risks than previously believed 2
... which is causing confusion among scientists, //...the scientist work overtime to decipher the reason...ive, queen bee, food and the young. Many years ag... leave the hive to be ransacked by honey bees from...
...could not seem to keep up with the other children ...hings compared to the other children. Her running ...ses it was found that she has CMT, Charcot-Marie-T...nd that her father and her brother Tony too suffer...
... tract infection. Wan et al reviewed //the clinica... and treatment. This study is important since urin...es of unexplained fevers in infants with an overal... 10%. All the patients in this study underwent ren...
...s interfere with the therapeutic effects of chemot...review of the use of antioxidants during chemother...s, tumor response, and the patient’s ability to to...mplications for patients whose oncologists discour...
Other Medicine News:Health News:Vanishing Honey Bees 2Health News:Cure for CMT 2Health News:Antioxidants May Aid Chemotherapy Patients 2
(Date:12/2/2008)...c. 2 Horizon Therapeutics, Inc., a...announced that two pivotal,Phase 3 trials evaluat...T-501,met all primary endpoints. HZT-501, a nove...taining ibuprofen and famotidine, demonstrated a,...ce of non-steroidal,anti-inflammatory drug (NSAID...
(Date:12/1/2008)... CHICAGO, Dec. 2 A stu...EM), a new technique for imaging the breast, is no...ormonal status, two factors that limit the effecti...g cancer. Results will be presented today at the a... America (RSNA). , , "The ability of PEM t...
(Date:12/1/2008)...1 S*BIO Pte Ltd today announced th...18, a potent and orally-active JAK2 inhibitor, in ...with chronic idiopathic myelofibrosis (CIMF). , ...ty and tolerability of SB1518 in patients with CIM... Phase 1 part of the study will assess the safety ...
(Date:12/1/2008)...hows the Prox1 gene is a two-way switch that, if t...e reprogrammed so that they lose their identity an..., MEMPHIS, Tenn., Dec. 1 /PRNewswire-USNewswire/...spital have discovered that a certain differentiat...at it requires the constant expression of a gene c...
Breaking Medicine Technology:Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 1JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 2JAMA Commentary Opposes Criminal Punishment for HIV Exposure Transmission 6916 3Kowa Company Ltd Acquires ProEthic Pharmaceuticals Inc 6913 1Kowa Company Ltd Acquires ProEthic Pharmaceuticals Inc 6913 2Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 1Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 2Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals 6909 3Huifeng Bio Pharmaceutical 28HFGB 29 to Release Second Quarter 2008 Earnings Results on August 15 2008 6904 1
...ion during the,early post-operative period compare...ion in nausea in the female,patient population com... CeNeS Pharmaceuticals plc (AIM:,CEN), the Cambrid...tional data from post-hoc analysis of the recent P...nide) in over 500 patients,with post-operative pai...
...0%; mso-hyphenate: none">,BUDAPEST, Hungary, June,...sands of patients with cancer from suffering,unnec...ngress of,the European Association for Palliative ...ated whether this first in class novel,formulation...,duration of effect, mirroring the breakthrough pa...
Other Medicine Technology:Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 2Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 3Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 4Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 5Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 6Further Statistical Analysis of the Recent Phase III trial on Lead,Product M6G Shows Additional Benefits 7Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 2Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 3Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 4Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 5Trial Results with Intranasal Fentanyl Hold Promise for Treatment,of Breakthrough Pain in Cancer 6
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
...ce laboratory and a worldwide leader in innovative...an extensive test menu of highly complex and uniqu.... Owned by the University of Utah, ARUP Laboratori... university teaching hospitals and children's hosp...
Medicine Products: